Company Profile

Reliq Health Technologies is a rapidly growing, profitable telehealth company. Reliq is targeting the $100 Billion virtual care market for chronic disease management. Reliq’s iUGO Care software platform allows clinicians to provide Medicare-billable remote patient monitoring and other virtual care services. The average physician can generate over $1 Million in new revenue per year at over 75% profit margins by using Reliq’s software. The company achieved profitability in Q3 2021 and expects to end the year at a revenue run rate of $2 Million/month. Reliq has a clear path to $120 Million in revenue in 2023 at 45% EBITDA margins. The company expects to uplist to the NASDAQ in 2022.

Corporate Speaker

Lisa Crossley Reliq Health

Lisa Crossley, PhD, P.Eng.

Dr. Crossley is an experienced healthcare technology executive. Prior to joining Reliq, she was the CEO of VitalHub Corp., CEO at Quantum Dental Technologies and President & CEO at Natrix Separations. She currently sits on the Board of Directors for Genome Alberta and has held numerous Board appointments during her career. She has raised more than $60M in venture capital and angel financing in the US and Canada and has built customer bases in North America, Europe & Asia. Dr. Crossley has a BSc in Anatomy & Cell Biology from McGill University and a B.Eng. and PhD in Chemical Engineering from Queen’s University. She is a license Professional Engineer in the Province of Ontario.

Company Website

Stock Info: